Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1 Pt 2
pubmed:dateCreated
1989-6-1
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0041-1345
pubmed:author
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1726-8
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:2652564-Adult, pubmed-meshheading:2652564-Antilymphocyte Serum, pubmed-meshheading:2652564-Azathioprine, pubmed-meshheading:2652564-Clinical Trials as Topic, pubmed-meshheading:2652564-Cyclosporins, pubmed-meshheading:2652564-Diabetic Neuropathies, pubmed-meshheading:2652564-Drug Therapy, Combination, pubmed-meshheading:2652564-Female, pubmed-meshheading:2652564-Graft Rejection, pubmed-meshheading:2652564-Graft Survival, pubmed-meshheading:2652564-Humans, pubmed-meshheading:2652564-Immunosuppression, pubmed-meshheading:2652564-Kidney Transplantation, pubmed-meshheading:2652564-Male, pubmed-meshheading:2652564-Methylprednisolone, pubmed-meshheading:2652564-Prednisone, pubmed-meshheading:2652564-Prognosis, pubmed-meshheading:2652564-Random Allocation, pubmed-meshheading:2652564-Transplantation, Homologous
pubmed:year
1989
pubmed:articleTitle
Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
pubmed:affiliation
Department of Surgery, University of Wisconsin School of Medicine, Madison.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study